Loading...

MedXY AI/MedXY News/Tag: cardiovascular risk

MedXY News

EnglishTag

cardiovascular risk

84 all articles · 20 / page

Ask MedXY AI

clinical trial type 2 diabetes heart failure immunotherapy obesity atrial fibrillation Cardiology oncology cardiovascular risk biomarkers clinical trials public health Hypertension critical care breast cancer artificial intelligence Alzheimer's disease diabetes nutrition chronic kidney disease cardiovascular disease Pediatrics

Latest news

Tag

Preoperative Cardiovascular Risk Does Not Alter Outcomes of Renin-Angiotensin System Inhibitor Use Before Major Noncardiac Surgery: Insights from a Secondary Analysis of the STOP-or-NOT Trial

Preoperative Cardiovascular Risk Does Not Alter Outcomes of Renin-Angiotensin System Inhibitor Use Before Major Noncardiac Surgery: Insights from a Secondary Analysis of the STOP-or-NOT Trial

A secondary analysis of the STOP-or-NOT trial shows that preoperative cardiovascular risk stratification does not impact postoperative outcomes related to continuing or discontinuing renin-angiotensin system inhibitors before major noncardi

Section: CardiologyOct 8, 2025

Mobile Text Messaging Enhances Glycemic and Blood Pressure Control in Adults with Uncontrolled Type 2 Diabetes

Mobile Text Messaging Enhances Glycemic and Blood Pressure Control in Adults with Uncontrolled Type 2 Diabetes

A randomized trial in China shows that a 12-month mobile message-based intervention modestly improves HbA1c and systolic blood pressure in patients with uncontrolled type 2 diabetes, supporting mHealth strategies to manage cardiovascular ri

Section: CardiologyOct 8, 2025

Obicetrapib: A Promising Advance in LDL Cholesterol Lowering for High Cardiovascular Risk Patients

Obicetrapib: A Promising Advance in LDL Cholesterol Lowering for High Cardiovascular Risk Patients

Obicetrapib significantly reduces LDL cholesterol by nearly 30% in high-risk cardiovascular patients on maximal lipid therapy, with a safety profile comparable to placebo, representing a potential novel agent in managing familial hyperchole

Section: CardiologyOct 7, 2025

Interleukin-17 Inhibitors and Cardiovascular Risk: Evaluating Early Major Adverse Cardiovascular Events

Interleukin-17 Inhibitors and Cardiovascular Risk: Evaluating Early Major Adverse Cardiovascular Events

A national database study finds no significant increase in early major adverse cardiovascular events (MACEs) after starting IL-17 inhibitors in psoriasis and related diseases, although a modest risk cannot be excluded.

Section: Allergy & ImmunologyOct 7, 2025

Lower High Blood Lipids Risk: Avoid Common Pitfalls and Embrace 4 Healthy Habits

Lower High Blood Lipids Risk: Avoid Common Pitfalls and Embrace 4 Healthy Habits

High blood lipids impact over 300 million people in China, often silently increasing cardiovascular risk. Learn to avoid common misconceptions and adopt four scientifically backed habits to improve your blood lipid profile and heart health.

Section: CardiologyOct 7, 2025

Intermittent Fasting: Benefits, Risks, and What Recent Research Reveals

Intermittent Fasting: Benefits, Risks, and What Recent Research Reveals

Intermittent fasting has gained popularity for its metabolic and weight-loss benefits, but new research links short eating windows to increased cardiovascular risks, urging caution and personalized approaches.

Section: Family Medicine & NutritionOct 6, 2025

Is More Sleep Better for Cardiovascular Health? Unveiling Risks of Long Sleep Duration and the Protective Role of the Mediterranean Diet

Is More Sleep Better for Cardiovascular Health? Unveiling Risks of Long Sleep Duration and the Protective Role of the Mediterranean Diet

Long sleep duration is linked to increased cardiovascular events in coronary heart disease patients, but adherence to a Mediterranean diet may mitigate these risks, emphasizing sleep’s impact on heart health.

Section: CardiologyOct 6, 2025

Association of Testosterone-Induced Neutrophil and Monocyte Elevation with Thromboembolic Risk: Insights from the TRAVERSE Trial

Association of Testosterone-Induced Neutrophil and Monocyte Elevation with Thromboembolic Risk: Insights from the TRAVERSE Trial

The TRAVERSE trial reveals that testosterone replacement therapy elevates neutrophil and monocyte counts in hypogonadal men, correlating with increased venous thromboembolism and cardiovascular event risk, underscoring the need to monitor t

Section: CardiologyOct 5, 2025

Impact of E-cigarette Use on Cardiovascular Risk, Lung Function, and Clinical Outcomes in Smokers: Insights from a Randomised Placebo-Controlled Trial

Impact of E-cigarette Use on Cardiovascular Risk, Lung Function, and Clinical Outcomes in Smokers: Insights from a Randomised Placebo-Controlled Trial

This review synthesizes trial evidence showing that nicotine-containing e-cigarettes modestly improve lipid profiles but cause no significant changes in lung function or other cardiovascular markers compared to cigarette substitutes in smok

Section: CardiologyOct 5, 2025

Decoding 10-Year Cardiovascular Risk in Ethiopia: The Impact of Individual and Community Factors

Decoding 10-Year Cardiovascular Risk in Ethiopia: The Impact of Individual and Community Factors

A population-based study in Ethiopia reveals 7.3% of adults aged 40-69 face a 10-year cardiovascular disease risk ≥10%, influenced by urban residence, education, physical activity, employment status, and climate factors.

Section: CardiologyOct 5, 2025

Recent Advances in Cinnamon and Its Extracts: Clinical Applications and Therapeutic Potentials Across Metabolic, Cardiovascular, Cognitive, and Infectious Diseases

Recent Advances in Cinnamon and Its Extracts: Clinical Applications and Therapeutic Potentials Across Metabolic, Cardiovascular, Cognitive, and Infectious Diseases

A decade of research highlights cinnamon’s benefits in glycemic control, lipid modulation, anti-inflammatory effects, cognitive enhancement, and antimicrobial activity, supporting its adjunctive clinical use and revealing promising therapeu

Section: CardiologyOct 5, 2025

Asthma and the Risk of Degenerative Valvular Heart Disease: Insights from a Large Prospective Cohort Study

Asthma and the Risk of Degenerative Valvular Heart Disease: Insights from a Large Prospective Cohort Study

This study demonstrates that asthma modestly increases the risk of degenerative valvular heart diseases, highlighting the need for cardiovascular vigilance in asthmatic individuals.

Section: Allergy & ImmunologyOct 5, 2025

Global Impact of Cardiovascular Risk Factors on Lifetime Cardiovascular Disease Burden and Mortality: A Comprehensive Evidence Synthesis

Global Impact of Cardiovascular Risk Factors on Lifetime Cardiovascular Disease Burden and Mortality: A Comprehensive Evidence Synthesis

This review integrates data from over two million individuals globally, showing that absence of five key cardiovascular risk factors at age 50 confers a life expectancy advantage exceeding a decade, with midlife modification of hypertension

Section: CardiologyOct 5, 2025

Evolocumab for Intensive LDL Cholesterol Reduction in Autoimmune and Inflammatory Disease Patients: Insights from the FOURIER Trial

Evolocumab for Intensive LDL Cholesterol Reduction in Autoimmune and Inflammatory Disease Patients: Insights from the FOURIER Trial

Evolocumab significantly lowers LDL cholesterol and substantially reduces cardiovascular events in patients with autoimmune/inflammatory diseases alongside statin therapy, according to the FOURIER trial analysis.

Section: CardiologyOct 3, 2025

AI-Driven Quantitative CT Reveals Higher Relative Cardiovascular Risk from Coronary Plaque in Women: Insights from the CONFIRM2 Registry

AI-Driven Quantitative CT Reveals Higher Relative Cardiovascular Risk from Coronary Plaque in Women: Insights from the CONFIRM2 Registry

AI-based quantitative CT analysis demonstrates that coronary plaque features, while more prevalent in men, confer a disproportionately higher relative risk of major adverse cardiovascular events in women, highlighting the need for sex-speci

Section: AIOct 3, 2025

Balancing Benefits and Harms of Intensive Blood Pressure Control Across Cardiovascular Risk Levels

Balancing Benefits and Harms of Intensive Blood Pressure Control Across Cardiovascular Risk Levels

Intensive blood pressure control reduces cardiovascular events across all risk levels, with greater absolute benefits in higher-risk patients despite increased adverse events, supporting tailored treatment based on cardiovascular risk.

Section: CardiologyOct 3, 2025

Exploring the Link Between the Triglyceride-Glucose Index and Hypertension Incidence in Japanese Adults

Exploring the Link Between the Triglyceride-Glucose Index and Hypertension Incidence in Japanese Adults

This study highlights the association between the triglyceride-glucose index and the incidence of hypertension in Japanese adults, emphasizing its potential as a predictive marker for cardiovascular health.

Section: CardiologyOct 3, 2025

Insulin Resistance and Serum Thyroxine as Key Factors in Differentiated Thyroid Carcinoma and Malignant Cytology

Insulin Resistance and Serum Thyroxine as Key Factors in Differentiated Thyroid Carcinoma and Malignant Cytology

This study reveals that increased serum free thyroxine and insulin resistance-associated factors are linked to higher malignancy risk in thyroid nodules, suggesting a complex interplay between metabolic and hormonal factors in thyroid cance

Section: Clinical UpdatesOct 3, 2025

AI-Powered Coronary Calcium Screening: Transforming Cardiovascular Risk Assessment in the Veterans Affairs Health System

AI-Powered Coronary Calcium Screening: Transforming Cardiovascular Risk Assessment in the Veterans Affairs Health System

AI-CAC enables automated, accurate coronary artery calcium scoring from routine chest CTs, offering scalable, opportunistic cardiovascular risk stratification across diverse populations.

Section: AIOct 2, 2025

Silent Damage: Blood Pressure and Subclinical Cardiovascular Injury in Adolescents—Insights from the SHIP AHOY Study

Silent Damage: Blood Pressure and Subclinical Cardiovascular Injury in Adolescents—Insights from the SHIP AHOY Study

The SHIP AHOY Study demonstrates that even modest elevations in blood pressure during adolescence are linked to a greater burden of subclinical target organ injury, underscoring the importance of early detection and intervention.

Section: CardiologyOct 2, 2025

Prev 1 2 3 4 5 Next